000 01839 a2200517 4500
005 20250516020900.0
264 0 _c20110331
008 201103s 0 0 eng d
022 _a1365-2141
024 7 _a10.1111/j.1365-2141.2010.08463.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _avan Tilburg, Cornelis M
245 0 0 _aImpact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.
_h[electronic resource]
260 _bBritish journal of haematology
_cFeb 2011
300 _a433-40 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAmbulatory Care
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug Administration Schedule
650 0 4 _aFemale
650 0 4 _aFever
_xchemically induced
650 0 4 _aHospitalization
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aNeoplasm, Residual
650 0 4 _aOpportunistic Infections
_xchemically induced
650 0 4 _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma
_xcomplications
650 0 4 _aPrognosis
650 0 4 _aProspective Studies
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aSanders, Elisabeth A M
700 1 _aNibbelke, Elisabeth E
700 1 _aPieters, Rob
700 1 _aRevesz, Tom
700 1 _aWesters, Paul
700 1 _aWolfs, Tom F W
700 1 _aBierings, Marc B
773 0 _tBritish journal of haematology
_gvol. 152
_gno. 4
_gp. 433-40
856 4 0 _uhttps://doi.org/10.1111/j.1365-2141.2010.08463.x
_zAvailable from publisher's website
999 _c20506879
_d20506879